Chris Hancock elected as a Fellow of Royal Academy of Engineering

Creo Medical’s Founder and Chief Technology Officer, Professor Chris Hancock, has been elected as a Fellow of the Royal Academy of Engineering (RAEng).

The Royal Academy of Engineering has elected 72 leading figures in the field of engineering and technology to its Fellowship. The group comprises 60 Fellows, seven International Fellows and five Honorary Fellows, each of whom has made exceptional contributions to their own sector, pioneering new innovations, leading progress in business or academia, providing high level advice to government, or promoting wider understanding of engineering and technology.

Chris has over 25 years of experience in medical device development. He holds a personal Chair in the Medical Microwave Systems Research Group at Bangor University, where he developed a new course in microwave engineering applied to medicine, and has supervised and mentored a number of students that have  gone on to become key members of the Creo Medical engineering team (many have gained higher degrees under his supervision). He is a Fellow of the Institute of Physics, a Chartered Physicist, Fellow of the Institute of Engineering and Technology, a Chartered Engineer and a Senior Member of the IEEE. He also became a Fellow of the Learned Society of Wales in 2022. Chris is a named inventor and lead author on over 1200 patents/patent applications and journal publications, and in 2019 was named in the Sunday Times’ Maserati 100 annual list of inspiring entrepreneurs, and awarded the Institute of Physics Katherine Burr Blodgett Gold Medal and Prize for his work in electrosurgery.

Chris was also appointed as a Royal Academy of Engineering Visiting Professor at UCL in July 2019, and has since given presentations/lectures on how engineering and medicine can be brought together to develop products that produce better clinical outcomes for patients all over the world. He also mentored a number of undergraduate and postgraduate students interested in developing start-up businesses.

The new Fellows will be formally admitted to the Academy at a special ceremony in London on 8 November, when each Fellow will sign the roll book. In joining the Fellowship, they will add their unique capabilities to the Academy’s mission to harness the power of engineering to create a sustainable society and an inclusive economy for all.

Chris Hancock, Chief Technology Officer and Founder of Creo Medical, said:

It is a great honour to be elected to the Fellowship of the Royal Academy of Engineering, and to join a group of individuals who have contributed so much to the field.  I am truly humbled and incredibly grateful for the acknowledgement and support I have received from my peers.


Sir Jim McDonald FREng FRSE, President of the Royal Academy of Engineering, added:

I am delighted to welcome such an array of enormously talented people to the Fellowship of the Royal Academy of Engineering. From industry and enterprise to education and government – both national and international – these are some of our most pioneering and distinguished engineers and technologists.

 “In an uncertain world, one thing is certain – engineering skills, vision and leadership will play a crucial part in addressing the escalating domestic and global challenges that we face today. The combined connectivity, professionalism, experience and wisdom of the new Fellows who join us today will greatly enrich the expertise and support we can provide to the government and to society in general.

Posted 09/22/22

For press enquiries please contact For all other enquiries please visit our Contact page.

Further news

19 March 2024

Welsh Labour Leader visits Creo’s facilities


05 February 2024

Strategic Collaboration with Khalifa University of Science and Technology, Abu Dhabi


31 January 2024

Roll-out of Speedboat® UltraSlim reaches Asia Pacific


10 January 2024

First Use of Speedboat® UltraSlim in Latin America


13 December 2023

First European Speedboat® UltraSlim procedure marks early commercial launch


01 November 2023

Speedboat® UltraSlim: US FDA Clearance


25 October 2023

Speedboat UltraSlim: EU launch accelerated by 18 months


12 September 2023

Half Year Report: H1-2023


19 June 2023

Speedboat Inject cleared for upper GI use in Europe


01 June 2023

Speedboat™ Inject selected by NICE for assessment